Physic Ventures
28
12M
15
1.65
4
0.46
7
- Stages of investment
- Areas of investment
Summary
Physic Ventures appeared to be the VC, which was created in 2006. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the San Francisco.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Physic Ventures, startups are often financed by Flybridge Capital Partners, Flagship Pioneering, Venrock. The meaningful sponsors for the fund in investment in the same round are Flagship Pioneering, DFJ, Unilever Ventures. In the next rounds fund is usually obtained by Apsara Capital, The Westly Group, Flagship Pioneering.
Comparing to the other companies, this Physic Ventures performs on 10 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2011. The higher amount of exits for fund were in 2019. The average startup value when the investment from Physic Ventures is 100-500 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Pharmaca, Recyclebank, Elixir Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Software, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Besides them, we counted 2 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 4
- Exits
- 7
- Rounds per year
- 1.65
- Follow on index
- 0.46
- Investments by industry
- Health Care (8)
- E-Commerce (8)
- Biotechnology (7)
- Software (6)
- Health Diagnostics (5) Show 30 more
- Investments by region
-
- United States (28)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 7M
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
- Avg. multiplicator
- 0.09
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Luxexcel | 21 Sep 2018 | Manufacturing, Augmented Reality, Virtual Reality, Wearables, Eyewear, 3D Printing, Printing | Late Stage Venture | 0 | Eindhoven, Netherlands, North Brabant |
| Novomer | 07 Nov 2007 | Sustainability, Energy Efficiency | Early Stage Venture | 6M | United States, Massachusetts |
| T2 Biosystems | 26 May 2010 | Biotechnology, Health Care, Health Diagnostics | Late Stage Venture | 15M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.